Ex vivo Detection and Characterization of Hepatitis B Virus-Specific CD8(+) T Cells in Patients Considered Immune Tolerant

Cited 1 time in webofscience Cited 0 time in scopus
  • Hit : 110
  • Download : 0
In this study, we aimed to detect and characterize ex vivo virus-specific CD8(+) T cells in patients with immune-tolerant hepatitis B virus (HBV) infection. We investigated a Korean chronic hepatitis B cohort composed of 15 patients in the immune-tolerant phase, 17 in the immune-active phase, and 13 under antiviral treatment. We performed enzyme-linked immunospot (ELISpot) assays ex vivo and intracellular cytokine staining after in vitro culture. We also performed ex vivo multimer staining assays and examined the expression of programmed death-1 (PD-1) and CD127 in pentamer-positive cells. Ex vivo ELISpot revealed that HBV-specific T cell function was weaker in immune-tolerant patients than in those under antiviral treatment. In vitro culture of peripheral blood mononuclear cells for 10 days revealed that HBV-specific CD8(+) T cells produced interferon-y in some immune-tolerant patients. We detected HBV-specific CD8(+) T cells ex vivo (using the HBV core(18-27) pentamer) in patients from all three groups. The PD-1(+) subset of pentamer(+) CD8(+) T cells was smaller ex vivo in the immune-tolerant phase than in the immune-active phase or under antiviral treatment. Interestingly, the proportion of PD-1(+) CD8(+) T cells in HBV-specific CD8(+) T cells correlated with patient age when all enrolled patients were analyzed. Overall, HBV-specific CD8(+) T cells are present in patients considered as immune-tolerant, although their ex vivo functionality is significantly weaker than that in patients under antiviral treatment (P < 0.05). Despite the high viral load, the proportion of PD-1 expression in HBV-specific CD8(+) T cells is lower in the immune-tolerant phase than in other phases. Our results indicate appropriate stimulation may enhance the effector function of HBV-specific CD8(+) T cells in patients considered as being in the immune-tolerant phase.
Publisher
FRONTIERS MEDIA SA
Issue Date
2019-06
Language
English
Article Type
Article
Citation

FRONTIERS IN IMMUNOLOGY, v.10

ISSN
1664-3224
DOI
10.3389/fimmu.2019.01319
URI
http://hdl.handle.net/10203/262804
Appears in Collection
MSE-Journal Papers(저널논문)
Files in This Item
There are no files associated with this item.
This item is cited by other documents in WoS
⊙ Detail Information in WoSⓡ Click to see webofscience_button
⊙ Cited 1 items in WoS Click to see citing articles in records_button

qr_code

  • mendeley

    citeulike


rss_1.0 rss_2.0 atom_1.0